LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 183

Suchoptionen

  1. Artikel: To Take or Not to Take: The Dilemma With Marginal Donor Heart?

    Park, Jin Joo

    Korean circulation journal

    2023  Band 53, Heft 4, Seite(n) 268–270

    Sprache Englisch
    Erscheinungsdatum 2023-05-10
    Erscheinungsland Korea (South)
    Dokumenttyp Editorial
    ZDB-ID 2557464-4
    ISSN 1738-5520
    ISSN 1738-5520
    DOI 10.4070/kcj.2023.0045
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: On-Treatment Diastolic Blood Pressure: When Is It Too High?

    Park, Jin Joo

    Korean circulation journal

    2022  Band 52, Heft 6, Seite(n) 475–477

    Sprache Englisch
    Erscheinungsdatum 2022-06-03
    Erscheinungsland Korea (South)
    Dokumenttyp Editorial
    ZDB-ID 2557464-4
    ISSN 1738-5520
    ISSN 1738-5520
    DOI 10.4070/kcj.2022.0126
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes.

    Park, Jin Joo

    Diabetes & metabolism journal

    2021  Band 45, Heft 2, Seite(n) 146–157

    Abstract: The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for ...

    Abstract The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients with DM have a worse prognosis than those without DM. Diabetes can cause myocardial ischemia via micro- and macrovasculopathy and can directly exert deleterious effects on the myocardium. Hyperglycemia, hyperinsulinemia, and insulin resistance can cause alterations in vascular homeostasis. Then, reduced nitric oxide and increased reactive oxygen species levels favor inflammation leading to atherothrombotic progression and myocardial dysfunction. The classification, diagnosis, and treatment of HF for a patient with and without DM remain the same. Until now, drugs targeting neurohumoral and metabolic pathways improved mortality and morbidity in HF with reduced ejection fraction (HFrEF). Therefore, all HFrEF patients should receive guideline-directed medical therapy. By contrast, drugs modulating neurohumoral activity did not improve survival in HF with preserved ejection fraction (HFpEF) patients. Trials investigating whether sodium-glucose cotransporter-2 inhibitors are effective in HFpEF are on-going. This review will summarize the epidemiology, pathophysiology, and treatment of HF in diabetes.
    Mesh-Begriff(e) Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/drug therapy ; Heart Failure/diagnosis ; Heart Failure/epidemiology ; Heart Failure/etiology ; Humans ; Myocardium ; Sodium-Glucose Transporter 2 Inhibitors ; Stroke Volume
    Chemische Substanzen Sodium-Glucose Transporter 2 Inhibitors
    Sprache Englisch
    Erscheinungsdatum 2021-03-25
    Erscheinungsland Korea (South)
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2602402-0
    ISSN 2233-6087 ; 2233-6087
    ISSN (online) 2233-6087
    ISSN 2233-6087
    DOI 10.4093/dmj.2020.0282
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes.

    Park, Jin Joo

    Diabetes & metabolism journal

    2021  Band 45, Heft 5, Seite(n) 796

    Sprache Englisch
    Erscheinungsdatum 2021-09-30
    Erscheinungsland Korea (South)
    Dokumenttyp Published Erratum
    ZDB-ID 2602402-0
    ISSN 2233-6087 ; 2233-6087
    ISSN (online) 2233-6087
    ISSN 2233-6087
    DOI 10.4093/dmj.2021.0239
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Topping Off the Pill Box: Dapagliflozin, Heart Failure, and Polypharmacy.

    Park, Jin Joo / Greenberg, Barry

    JACC. Heart failure

    2023  Band 11, Heft 10, Seite(n) 1394–1396

    Mesh-Begriff(e) Humans ; Heart Failure/drug therapy ; Polypharmacy ; Benzhydryl Compounds/therapeutic use ; Glucosides/therapeutic use ; Stroke Volume ; Ventricular Function, Left
    Chemische Substanzen dapagliflozin (1ULL0QJ8UC) ; Benzhydryl Compounds ; Glucosides
    Sprache Englisch
    Erscheinungsdatum 2023-08-09
    Erscheinungsland United States
    Dokumenttyp Editorial ; Comment
    ZDB-ID 2705621-1
    ISSN 2213-1787 ; 2213-1779
    ISSN (online) 2213-1787
    ISSN 2213-1779
    DOI 10.1016/j.jchf.2023.06.033
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: Computed Tomography for Assessment of Left Atrial Appendage Function.

    Park, Jin Joo

    Korean circulation journal

    2018  Band 49, Heft 2, Seite(n) 181–182

    Sprache Englisch
    Erscheinungsdatum 2018-11-07
    Erscheinungsland Korea (South)
    Dokumenttyp Editorial
    ZDB-ID 2557464-4
    ISSN 1738-5520
    ISSN 1738-5520
    DOI 10.4070/kcj.2018.0355
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Current status of heart failure: global and Korea.

    Park, Jin Joo / Choi, Dong-Ju

    The Korean journal of internal medicine

    2020  Band 35, Heft 3, Seite(n) 487–497

    Abstract: Heart failure (HF) is a condition in which the heart is unable to pump enough blood to meet the body's needs for blood and oxygen. Thus, HF is a grave disease with high morbidity and mortality. Because the prevalence of and exposure to the risk factors ... ...

    Abstract Heart failure (HF) is a condition in which the heart is unable to pump enough blood to meet the body's needs for blood and oxygen. Thus, HF is a grave disease with high morbidity and mortality. Because the prevalence of and exposure to the risk factors for HF increase with age, the prevalence of HF has been increasing in an aging society, including Korea. The vast advancement of medical and device therapy has improved the outcomes of HF, but significant residual risk still exists, and the benefit is confined to patients with reduced ejection fraction. Finding effective treatment for HF with preserved ejection fraction and identification of groups who benefit from drug and device therapy remain challenging. In this review, we illustrate the epidemiology, temporal trends, and current status of medical and device therapy, including heart transplantation, as well as emerging treatments for HF in Korea and worldwide.
    Mesh-Begriff(e) Heart Failure/diagnosis ; Heart Failure/epidemiology ; Heart Failure/therapy ; Humans ; Republic of Korea/epidemiology ; Risk Factors ; Stroke Volume ; Ventricular Dysfunction, Left
    Sprache Englisch
    Erscheinungsdatum 2020-04-29
    Erscheinungsland Korea (South)
    Dokumenttyp Journal Article ; Review
    ZDB-ID 639023-7
    ISSN 2005-6648 ; 1226-3303
    ISSN (online) 2005-6648
    ISSN 1226-3303
    DOI 10.3904/kjim.2020.120
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction.

    Brann, Alison / Miller, James / Eshraghian, Emily / Park, Jin Joo / Greenberg, Barry

    European journal of heart failure

    2023  Band 25, Heft 10, Seite(n) 1755–1765

    Abstract: Aims: Patients with heart failure with preserved ejection fraction (HFpEF) are at high risk for hospitalization and mortality and many of these patients experience a deterioration in left ventricular ejection fraction (LVEF) over time. Global ... ...

    Abstract Aims: Patients with heart failure with preserved ejection fraction (HFpEF) are at high risk for hospitalization and mortality and many of these patients experience a deterioration in left ventricular ejection fraction (LVEF) over time. Global longitudinal strain (GLS) is a sensitive marker of myocardial dysfunction that could help predict risk for future events in this population. We assessed whether GLS can predict adverse clinical outcomes and future deterioration in LVEF in patients with HFpEF.
    Methods and results: In this retrospective cohort study, patients with HFpEF were divided into groups according to abnormal GLS (>-15.8%) or normal GLS (<-15.8%).The primary outcomes were: a composite of cardiovascular mortality or heart failure hospitalization and deterioration in LVEF to <40%. Among the 311 patients with HFpEF, 128 patients (41%) had normal GLS and 183 patients (59%) had abnormal GLS. After a median follow-up of 4.6 years, the composite outcome occurred more commonly in patients with abnormal GLS compared to patients with normal GLS (62% vs. 44%; hazard ratio [HR] 1.74, 95% confidence interval [CI] 1.3-2.4, p < 0.001). Patients with abnormal GLS were also more likely to experience a deterioration in LVEF (19% vs. 10%; HR 2.2, 95% CI 1.2-4.3, p = 0.018). When assessed as a continuous variable, each 1% increase in GLS was associated with 10% increased odds for the composite outcome and 13% increased odds for deterioration in LVEF.
    Conclusion: In patients with HFpEF, abnormal GLS is common and is a strong predictor for clinical events and future deterioration in LVEF.
    Mesh-Begriff(e) Humans ; Ventricular Function, Left ; Stroke Volume ; Retrospective Studies ; Heart Failure ; Global Longitudinal Strain ; Prognosis ; Ventricular Dysfunction, Left/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2023-07-24
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 1483672-5
    ISSN 1879-0844 ; 1388-9842
    ISSN (online) 1879-0844
    ISSN 1388-9842
    DOI 10.1002/ejhf.2947
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Reply: Time to Diuretic in Acute Heart Failure.

    Park, Jin Joo / Choi, Dong-Ju

    JACC. Heart failure

    2018  Band 6, Heft 8, Seite(n) 723

    Mesh-Begriff(e) Diuretics ; Furosemide ; Heart Failure ; Humans ; Sodium Potassium Chloride Symporter Inhibitors
    Chemische Substanzen Diuretics ; Sodium Potassium Chloride Symporter Inhibitors ; Furosemide (7LXU5N7ZO5)
    Sprache Englisch
    Erscheinungsdatum 2018-07-30
    Erscheinungsland United States
    Dokumenttyp Letter ; Comment
    ZDB-ID 2705621-1
    ISSN 2213-1787 ; 2213-1779
    ISSN (online) 2213-1787
    ISSN 2213-1779
    DOI 10.1016/j.jchf.2018.06.005
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Reply: Finding a Balance Between Quality and Quantity of Data in Acute Heart Failure.

    Park, Jin Joo / Choi, Dong-Ju

    JACC. Heart failure

    2018  Band 6, Heft 7, Seite(n) 616

    Mesh-Begriff(e) Diuretics ; Heart Failure ; Humans
    Chemische Substanzen Diuretics
    Sprache Englisch
    Erscheinungsdatum 2018-06-28
    Erscheinungsland United States
    Dokumenttyp Letter ; Comment
    ZDB-ID 2705621-1
    ISSN 2213-1787 ; 2213-1779
    ISSN (online) 2213-1787
    ISSN 2213-1779
    DOI 10.1016/j.jchf.2018.04.013
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang